нет
References1. Поляков ДС, Фомин ИВ, Беленков ЮН, Мареев ВЮ,Агеев ФТ, Артемьева ЕГ и др. Хроническая сердечная недостаточность в Российской Федерации: что изменилось за 20 лет наблюдения? Результаты исследования ЭПОХА-ХС // Кардиология. 2021; 61 (4):414. Polyakov DS, Fomin IV, Belenkov YuN, Mareev VYu,Ageev FT, Artemjeva EG et al. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia. 2021. №61(4). С.4–14. https://doi.org/10.18087/cardio.2021.4.n1628.2. Khush KK, Cherikh WS, Chambers DC, Goldfarb S, Hayes D Jr,, Kucheryavaya AY et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-fifth adult heart transplantation report - focus theme: multiorgan transplantation // J Heart Lung Transplant, 2018; № 37 (10): 1155–1168.3. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC // Eur J Heart Fail. 2012; №14: 803–69.4. Steffel J, Rempel H, Breitenstein A, et al. Comprehensive cardiac resynchronization therapy optimization in the real world // Cardiol J . 2014; № 21: 316–24.5. Shultes KC, Shuster JE, Micek S, Vader JM, Balsara K, Itoh A, Tellor BR. Outcomes and Predictors of Early Infection after Heart Transplantation // Surg Infect (Larchmt). 2018; 19(5): 516-522. doi: 10.1089/sur.2017.295. 6. Solomon NA, McGiven JR, Alison PM, Ruygrok PN, Haydock DA, Coverdale HA, West TM. Changing donor and recipient demographics in a heart transplantation program: influence on early outcome // Ann Thorac Surg. 2004; 77(6): 2096-102. doi: 10.1016/j.athoracsur.2003.09.086. PMID: 15172275.7. Maisano F, Franzen O, Baldus S, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe // J Am Coll Cardiol. 2013; 62: 1052–61.8. Markus J. Wilhelm Long-term outcome following heart transplantation: current perspective // J Thorac Dis. 2015; 7(3): 549–551. 9. Lund LH, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report // focus theme: retransplantation. J Heart Lung Transplant. 2014; 33: 996–1008 10. Rodriguez Cetina Biefer H, Sündermann SH, Emmert MY, et al. Surviving 20 years after heart transplantation: a success story // Ann Thorac Surg. 2014; 97: 499–504